Relationship between serum N-terminal pro-brain natriuretic peptide level and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients

Electrolyte and Blood Pressure

Volumn 6, Issue 1, 2008, Pages 15-21

  Chung, Jong Hoon ^a   Yun, Na Ra ^a   Ahn, Chi Yong ^a   Lee, Wan Soo ^a   Kim, Hyun Lee ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

Continuous ambulatory peritoneal dialysis; Extracellular fluid; Pro brain natriuretic peptide (1 76)

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE MARKER; EXTRACELLULAR FLUID; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; M MODE ECHOCARDIOGRAPHY; MALE; PROTEIN BLOOD LEVEL; TOTAL BODY WATER; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 50849097241     PISSN: 17385997     EISSN: None     Source Type: Journal    
DOI: 10.5049/EBP.2008.6.1.15     Document Type: Article

References (20)

1. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
2. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9:S16-23, 1998
3. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patiets. Am J Kidney Dis 45(Suppl 3):S1-153, 2005
4. Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, et al.: Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 78:594-597, 1997
5. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al.: NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89:150-154, 2003
6. Kwon SH, On YK, Han DH, Lee SC, Jo YH, Lee NH, et al.: Usefulness of B-type Natriuretic Peptide in Congestive Heart Failure. Korean Circ J 33:695-700, 2003
7. DeFilippi CR, Fink JC, Nass CM, Chen H, Christenson R: N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis 46:35-44, 2005
8. Choi SY, Kim JA, Lee JE, Do YS, Jang EH, Bae HJ, et al.: Plasma Levels of N-terminal pro-brain Natriuretic Peptide (NT-proBNP) and Left Ventricular Function in Patients with Chronic Renal Failure. Korean J Nephrol 25: 413-421, 2006
9. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al.: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508-1515, 2001
10. Ganau A, Devereux RB, Romani MJ, de Simone G, Pickering TG, Saba PS, et al.: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550-1558, 1992
11. Snel YE, Brummer RJ, Doerga ME, Zelissen PM, Koppeschaar HP: Validation of extracellular water determination by bioelectrical impedance analysis in growth hormone-deficient adults. Ann Nutr Metab 39:242-250, 1995
12. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59:956-960, 1987
13. Stoddard MF, Pearson AC, Kern MJ, Ratcliff J, Mrosek DG, Labovitz AJ: Muence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation 79: 1226-1236, 1989
14. Brun P, Tribouilloy C, Duval AM, Iserin L, Meguira A, Pelle G, et al.: Left ventricnIar flow propagation during early filling is related to wall relaxation: a color M-mode Doppler analysis. J Am Coll Cardiol 20:420-432, 1992
15. Naganuma T, Sugimura K, Wada S, Yasumoto R, Sugimura T, Masuda C, et al.: The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22:437-444, 2002
16. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, et al.: Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J Kidney Dis 37:1201-1208, 2001
17. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, et al.: Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 95:C60-66, 2003
18. Su X., Brower G, Janicki JS, Chen YF, Oparil S, Dell'Italia LJ: Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J Mol Cell Cardiol 31:1927-1936, 1999
19. Dastoor H, Bernieh B, Boobes Y, Abouchacra S, Eltayeb E, Elhuda MN, et al.: Plasma BNP in patients on maintenance haemodialysis: a guide to management? J Hypertens 23:23-28, 2005
20. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET: Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 26:360-365, 2006